ID | 110538 |
Title Transcription | アタラシイ リウマチ チリョウホウ
|
Title Alternative | Clinical efficacy of anti-cytokine therapy in rheumatoid arthritis
|
Author |
Tani, Kenji
Department of Internal Medicine and Molecular Therapeutics, Course of Medical Oncology, The University of Tokushima School of Medicine
KAKEN Search Researchers
Sone, Saburo
Department of Internal Medicine and Molecular Therapeutics, Course of Medical Oncology, The University of Tokushima School of Medicine
Tokushima University Educator and Researcher Directory
KAKEN Search Researchers
|
Keywords | rheumatoid arthritis
tumor necrosis factor-α
etanercept
infliximab
|
Content Type |
Journal Article
|
Description | Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by the progressive destruction of joints. Cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, IL-6 and IL-8 have a critical role in the pathogenesis of RA. Recently, etanercept and infliximab, which block the action of TNF-α, can reduce the disease activity of RA. They act more rapidly to decrease symptoms and slow joint damage in patients with early active RA than methotrexate. This article describes recent studies on anti-cytokine therapy in RA.
|
Journal Title |
四国医学雑誌
|
ISSN | 00373699
|
NCID | AN00102041
|
Publisher | 徳島医学会
|
Volume | 58
|
Issue | 3
|
Start Page | 122
|
End Page | 126
|
Sort Key | 122
|
Published Date | 2002-06-15
|
EDB ID | |
FullText File | |
language |
jpn
|
TextVersion |
Publisher
|
departments |
University Hospital
Medical Sciences
|